JP2017523225A5 - - Google Patents

Download PDF

Info

Publication number
JP2017523225A5
JP2017523225A5 JP2017506964A JP2017506964A JP2017523225A5 JP 2017523225 A5 JP2017523225 A5 JP 2017523225A5 JP 2017506964 A JP2017506964 A JP 2017506964A JP 2017506964 A JP2017506964 A JP 2017506964A JP 2017523225 A5 JP2017523225 A5 JP 2017523225A5
Authority
JP
Japan
Prior art keywords
alkyl
substituted
carboxylic acid
formula
heterocycle
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017506964A
Other languages
English (en)
Japanese (ja)
Other versions
JP6577570B2 (ja
JP2017523225A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2015/068257 external-priority patent/WO2016020526A1/en
Publication of JP2017523225A publication Critical patent/JP2017523225A/ja
Publication of JP2017523225A5 publication Critical patent/JP2017523225A5/ja
Application granted granted Critical
Publication of JP6577570B2 publication Critical patent/JP6577570B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017506964A 2014-08-08 2015-08-07 インフルエンザウイルス感染に使用するためのインドール類 Expired - Fee Related JP6577570B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP14180331 2014-08-08
EP14180331.2 2014-08-08
PCT/EP2015/068257 WO2016020526A1 (en) 2014-08-08 2015-08-07 Indoles for use in influenza virus infection

Publications (3)

Publication Number Publication Date
JP2017523225A JP2017523225A (ja) 2017-08-17
JP2017523225A5 true JP2017523225A5 (enExample) 2019-08-22
JP6577570B2 JP6577570B2 (ja) 2019-09-18

Family

ID=51298610

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017506964A Expired - Fee Related JP6577570B2 (ja) 2014-08-08 2015-08-07 インフルエンザウイルス感染に使用するためのインドール類

Country Status (18)

Country Link
US (1) US10597390B2 (enExample)
EP (1) EP3177609A1 (enExample)
JP (1) JP6577570B2 (enExample)
KR (1) KR102488479B1 (enExample)
CN (1) CN106573920B (enExample)
AU (1) AU2015298876B2 (enExample)
BR (1) BR112017002370B1 (enExample)
CA (1) CA2954751C (enExample)
CL (1) CL2017000309A1 (enExample)
EA (1) EA201790266A1 (enExample)
IL (1) IL250408B (enExample)
MA (1) MA40547A (enExample)
MX (1) MX381488B (enExample)
PH (1) PH12017500207A1 (enExample)
SG (1) SG11201700956VA (enExample)
UA (1) UA124609C2 (enExample)
WO (1) WO2016020526A1 (enExample)
ZA (1) ZA201700952B (enExample)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2442809T3 (en) 2009-06-17 2016-12-19 Vertex Pharma Inhibitors of the replication of influenza virus
UA118010C2 (uk) 2011-08-01 2018-11-12 Вертекс Фармасьютікалз Інкорпорейтед Інгібітори реплікації вірусів грипу
SG11201700956VA (en) 2014-08-08 2017-03-30 Janssen Sciences Ireland Uc Indoles for use in influenza virus infection
MA42422A (fr) 2015-05-13 2018-05-23 Vertex Pharma Inhibiteurs de la réplication des virus de la grippe
JP6704416B2 (ja) 2015-05-13 2020-06-03 バーテックス ファーマシューティカルズ インコーポレイテッドVertex Pharmaceuticals Incorporated インフルエンザウイルスの複製の阻害剤を調製する方法
WO2017097234A1 (en) 2015-12-09 2017-06-15 Sunshine Lake Pharma Co., Ltd. Inhibitors of influenza virus replication, application methods and uses thereof
EP3400225B1 (en) * 2016-01-07 2021-11-10 Janssen Sciences Ireland Unlimited Company Pentanoic acids substituted by pyrrolo-[2-3,b]pyrimidine-pyridines for the treatment of influenza viral infections
WO2017133670A1 (en) * 2016-02-05 2017-08-10 Savira Pharmaceuticals Gmbh Pyridine and pyrimidine derivatives and their use in treatment, amelioration or prevention of influenza
WO2018033082A1 (en) * 2016-08-16 2018-02-22 Sunshine Lake Pharma Co., Ltd. Inhibitors of influenza virus replication, application methods and uses thereof
CN109641868B (zh) * 2016-08-30 2021-12-03 广东东阳光药业有限公司 流感病毒复制抑制剂及其使用方法和用途
RU2727772C1 (ru) * 2016-09-05 2020-07-23 Гуандун Рэйновент Байотек Ко., Лтд. Производные пиримидина против вируса гриппа
WO2018108125A1 (en) 2016-12-15 2018-06-21 Sunshine Lake Pharma Co., Ltd. Inhibitors of influenza virus replication and uses thereof
CA3047404A1 (en) 2016-12-23 2018-06-28 Aquinnah Pharmaceuticals, Inc. Compounds, compositions and methods of use
CN108276401B (zh) 2017-01-05 2020-12-22 广东东阳光药业有限公司 流感病毒复制抑制剂及其用途
CN110446711B (zh) 2017-03-02 2022-02-15 广东东阳光药业有限公司 流感病毒复制抑制剂及其用途
CN108727369B (zh) * 2017-04-25 2023-06-09 广东东阳光药业有限公司 流感病毒复制抑制剂及其用途
NZ767352A (en) * 2018-03-05 2023-05-26 Guangdong Raynovent Biotech Co Ltd Crystal form and salt form of pyridopyrazole compound and preparation method therefor
US12252487B2 (en) 2019-07-22 2025-03-18 Guangdong Raynovent Biotech Co., Ltd. Dominant salt forms of pyrimidine derivatives, and crystal forms thereof
CN113045475A (zh) * 2019-12-27 2021-06-29 上海泓博智源医药股份有限公司 一种5-溴-7-甲基吲哚的制备方法
KR20230079003A (ko) * 2020-07-20 2023-06-05 니도 바이오사이언시스, 인코포레이티드 안드로겐 수용체 조절제로서의 인돌 화합물
WO2022057842A1 (en) * 2020-09-18 2022-03-24 Sunshine Lake Pharma Co., Ltd. Preparation method of substituted pyrimidine piperazine compounds
IL320191A (en) * 2022-10-12 2025-06-01 Maze Therapeutics Inc Solute carrier family 6A member 19 inhibitors (SLC6A19) and methods of using them

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7507826B2 (en) 2004-03-30 2009-03-24 Vertex Pharmaceuticals Incorporated Azaindoles useful as inhibitors of JAK and other protein kinases
TW201412738A (zh) 2006-01-17 2014-04-01 Vertex Pharma 適合作為傑納斯激酶(janus kinase)抑制劑之氮雜吲哚
DK2442809T3 (en) * 2009-06-17 2016-12-19 Vertex Pharma Inhibitors of the replication of influenza virus
JP5876051B2 (ja) * 2010-09-08 2016-03-02 グラクソスミスクライン、インテレクチュアル、プロパティー、ディベロップメント、リミテッドGlaxosmithkline Intellectual Property Development Limited インフルエンザウィルス感染の治療に使用するためのインダゾール誘導体
AU2011343642A1 (en) * 2010-12-16 2013-05-02 Vertex Pharmaceuticals Incorporated Inhibitors of influenza viruses replication
KR20130128435A (ko) * 2010-12-16 2013-11-26 버텍스 파마슈티칼스 인코포레이티드 인플루엔자 바이러스 복제의 억제제
UA118010C2 (uk) * 2011-08-01 2018-11-12 Вертекс Фармасьютікалз Інкорпорейтед Інгібітори реплікації вірусів грипу
WO2013030138A1 (en) 2011-09-01 2013-03-07 F. Hoffmann-La Roche Ag Pyrrolopyrazine kinase inhibitors
WO2013184985A1 (en) 2012-06-08 2013-12-12 Vertex Pharmaceuticals Incorporated Inhibitors of influenza viruses replication
EP3068776B1 (en) 2013-11-13 2019-05-29 Vertex Pharmaceuticals Incorporated Inhibitors of influenza viruses replication
SG11201700956VA (en) 2014-08-08 2017-03-30 Janssen Sciences Ireland Uc Indoles for use in influenza virus infection
AR101401A1 (es) 2014-08-08 2016-12-14 Bayer Cropscience Ag Derivados de bipirazol, sustituidos con halógeno
AR101448A1 (es) 2014-08-08 2016-12-21 Bayer Cropscience Ag Compuestos sustituidos por halógeno
CN104592038A (zh) 2015-01-12 2015-05-06 烟台万润精细化工股份有限公司 一种5,5-二甲基-1,3-环己二胺的制备方法

Similar Documents

Publication Publication Date Title
JP2015024998A5 (enExample)
JP2020507589A5 (enExample)
JP2017531619A5 (enExample)
ZA202006378B (en) N-heterocyclic five-membered ring-containing capsid protein assembly inhibitor, pharmaceutical composition thereof, and use thereof
JP2019501879A5 (enExample)
JP2016518434A5 (enExample)
JP2020531422A5 (enExample)
JP2017531038A5 (enExample)
EA201992082A1 (ru) Ингибитор поверхностного антигена вируса гепатита b
JP2020532547A5 (enExample)
JP2019510034A5 (enExample)
JP2017517565A5 (enExample)
JP2017528503A5 (enExample)
RU2013121788A (ru) Ингибиторы репликации вич
JP2019500387A5 (enExample)
JP2014511891A5 (enExample)
JP2013542247A5 (enExample)
HRP20210038T1 (hr) Pirolopirimidini za uporabu u infekciji virusom gripe
JP2016540742A5 (enExample)
JP2016534063A5 (enExample)
JP2016510326A5 (enExample)
JP2015051983A5 (enExample)
HRP20211223T1 (hr) Heterociklički indoli za upotrebu kod infekcije virusom influence
RU2016104844A (ru) Производные n-мочевино замещенных аминокислот как модуляторы формил-пептидного рецептора
JP2019505529A5 (enExample)